Atlas Trials

A Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases

Clinical trial NCT04299646 · RECRUITING

Trial details

NCT number
NCT04299646
Sponsor
Centre Francois Baclesse
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Renal Cell CarcinomaRadiotherapy
Start date
2020-07-01
Primary completion
2027-04-01
Enrollment
77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.